Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment

Introduction. Especially dangerous are forecast of hemorrhagic complications of pneumonia. Therefore, the study of aggregation properties of platelets in patients with community acquired pneumonia third group is the most important task of modern pulmonology. Aim of this work was studying of the f...

Full description

Bibliographic Details
Main Authors: V. V. Syvolap, L. O. Kurilets, O. D. Ryazanova
Format: Article
Language:English
Published: Zaporozhye State Medical University 2016-06-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/76925/73884
_version_ 1818529004312854528
author V. V. Syvolap
L. O. Kurilets
O. D. Ryazanova
author_facet V. V. Syvolap
L. O. Kurilets
O. D. Ryazanova
author_sort V. V. Syvolap
collection DOAJ
description Introduction. Especially dangerous are forecast of hemorrhagic complications of pneumonia. Therefore, the study of aggregation properties of platelets in patients with community acquired pneumonia third group is the most important task of modern pulmonology. Aim of this work was studying of the features of ADP-induced platelet aggregation in patients with community acquired pneumonia third group. Material and methods. In an open prospective study included 50 patients with community acquired pneumonia the third group and 30 healthy individuals. The functional activity of platelets analyzed by the method of Born on platelet aggregation analyzer AR 2110 «SOLAR» (Belarus). As an inducer of aggregation used bacterial 5'-adenosine disodium salt dyphosphorus acid («Sigma Aldrich», USA) in a final concentration of 5 mM/l. Results. In patients with community acquired pneumonia 3-d group compared to the practically healthy individuals revealed a significant degree of inhibition of ADP-induced platelet aggregation by 37% (p<0.05). Also there was likely reduce the time of ADP-induced platelet aggregation at 46.7% (p<0.05). The rate of ADP-induced platelet aggregation in patients with community acquired pneumonia tended to decrease with 54.01±2.68% / min. to 46.00±3.99% / min. and almost reached the limits of statistical probability (p=0.057). Under the influence of treatment there was a further significant decrease only the degree of ADP-induced platelet aggregation by 12.5% (p<0.05). Indicators of time and rate of aggregation were not significantly changed. Conclusions. In patients with community acquired pneumonia 3-d group observed decrease of degree and time of ADP-induced platelet aggregation. There is a further decrease of the degree of ADP-induced aggregation during treatment, without significant alteration of speed and time aggregation.
first_indexed 2024-12-11T06:57:27Z
format Article
id doaj.art-9d0a0af28eac4d059a2a6392bb305f7f
institution Directory Open Access Journal
issn 2306-4145
2310-1210
language English
last_indexed 2024-12-11T06:57:27Z
publishDate 2016-06-01
publisher Zaporozhye State Medical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj.art-9d0a0af28eac4d059a2a6392bb305f7f2022-12-22T01:16:43ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102016-06-0134648Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatmentV. V. SyvolapL. O. KuriletsO. D. RyazanovaIntroduction. Especially dangerous are forecast of hemorrhagic complications of pneumonia. Therefore, the study of aggregation properties of platelets in patients with community acquired pneumonia third group is the most important task of modern pulmonology. Aim of this work was studying of the features of ADP-induced platelet aggregation in patients with community acquired pneumonia third group. Material and methods. In an open prospective study included 50 patients with community acquired pneumonia the third group and 30 healthy individuals. The functional activity of platelets analyzed by the method of Born on platelet aggregation analyzer AR 2110 «SOLAR» (Belarus). As an inducer of aggregation used bacterial 5'-adenosine disodium salt dyphosphorus acid («Sigma Aldrich», USA) in a final concentration of 5 mM/l. Results. In patients with community acquired pneumonia 3-d group compared to the practically healthy individuals revealed a significant degree of inhibition of ADP-induced platelet aggregation by 37% (p<0.05). Also there was likely reduce the time of ADP-induced platelet aggregation at 46.7% (p<0.05). The rate of ADP-induced platelet aggregation in patients with community acquired pneumonia tended to decrease with 54.01±2.68% / min. to 46.00±3.99% / min. and almost reached the limits of statistical probability (p=0.057). Under the influence of treatment there was a further significant decrease only the degree of ADP-induced platelet aggregation by 12.5% (p<0.05). Indicators of time and rate of aggregation were not significantly changed. Conclusions. In patients with community acquired pneumonia 3-d group observed decrease of degree and time of ADP-induced platelet aggregation. There is a further decrease of the degree of ADP-induced aggregation during treatment, without significant alteration of speed and time aggregation.http://zmj.zsmu.edu.ua/article/view/76925/73884PneumoniaADPPlatelet Aggregation
spellingShingle V. V. Syvolap
L. O. Kurilets
O. D. Ryazanova
Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
Zaporožskij Medicinskij Žurnal
Pneumonia
ADP
Platelet Aggregation
title Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
title_full Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
title_fullStr Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
title_full_unstemmed Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
title_short Features of ADP-induced platelet aggregation in patients with community-acquired pneumonia 3-d group and its changes during treatment
title_sort features of adp induced platelet aggregation in patients with community acquired pneumonia 3 d group and its changes during treatment
topic Pneumonia
ADP
Platelet Aggregation
url http://zmj.zsmu.edu.ua/article/view/76925/73884
work_keys_str_mv AT vvsyvolap featuresofadpinducedplateletaggregationinpatientswithcommunityacquiredpneumonia3dgroupanditschangesduringtreatment
AT lokurilets featuresofadpinducedplateletaggregationinpatientswithcommunityacquiredpneumonia3dgroupanditschangesduringtreatment
AT odryazanova featuresofadpinducedplateletaggregationinpatientswithcommunityacquiredpneumonia3dgroupanditschangesduringtreatment